CML Vaccine Therapy  -  CML - Chronic Myeloid Leukemia

                                   
CLINICAL TRIALS

DC Vaccination in CML (2015)
September 22, 2015,  ClinicalTrials.gov

A study looking at a new vaccine to treat leukaemia (WIN)
​February 1, 2011, Cancer Research UK

​Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
March 2006, clinicaltrials.gov
 
Safety of Peptide Vaccination for Patients With Myelodysplastic Syndrome
December 2005, clinicaltrials.gov


ARTICLES
​
PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies
2017, Leukemia

Wilm’s Tumor Vaccine Effective for CML
February 5, 2013,  Medical Automation

DNA vaccine for leukemia has early positive results
January 1, 2013, OncologyNurseAdvisor

Winning the Battle Against Leukemia: Positive Early Results in  Clinical Trial for DNA Vaccine
December 7, 2012, Science  Daily

Vaccines as consolidation therapy for myeloid leukemia
December 1, 2011, Expert Rev Hematol

Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice
August 25, 2011, Journal Blood

Inovio Pharmaceuticals' Prostate Cancer DNA Vaccine Demonstrates Strong T Cell Responses in Monkeys; Company on Track for Phase I Clinical Trial
June 29, 2011, PrNewswire

Southampton Scientists Develop New Cancer Vaccine
March 2011, Express Healthcare

Patient Trials of New Leukemia Cancer Vaccine Begun
January 31, 2011, Science Daily

Southampton scientists begin patient trials of new leukemia cancer vaccine
January 31, 2011, Physorg.com

BioSante Announces FDA Orphan Drug Designation For GVAX Chronic Myeloid Leukemia Cancer Vaccine
June 2010, Businesswire

WT1 PEPTIDE VACCINATION IN COMBINATION WITH IMATINIB THERAPY FOR A PATIENT WITH CML IN THE CHRONIC PHASE
April 2010, International Journal of Medical Sciences

Vaccine may cure chronic myeloid leukemia CML
January 10, 2010, Health Newstrack

Preliminary studies show cancer vaccine may reduce tumor cells in CML patients
January 2010, The Medical news

K562/GM-CSF immunotherapy reduces tumor burden in chronic myeloid leukemia patients with residual disease on imatinib mesylate
January  1, 2010, PublMed

Some Complete Molecular Responses Seen With CML Vaccine
March 1, 2006, CancerNetwork  

Vaccination of chronic myeloid leukemia patients with autologous in vitro cultured leukemic dendritic cells
2003, Leukemia
                                  

                                                         
                                    Return to Cure possible for CML?